News about "Bristol Myers Squibb"

Lupin Secures US FDA Approval for Lenalidomide Capsules

The approved Lenalidomide Capsules, bioequivalent to Revlimid by Bristol-Myers Squibb, will be produced at Lupin’s Pithampur site in India.

Bristol-Myers Squibb | 17/09/2025 | By Dineshwori

Alkermes appoints Joshua Reed as CFO

The newly-appointed CFO at Alkermes, Joshua Reed, brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics.

Bristol Myers Squibb | 13/09/2025 | By Dineshwori

Four Drugs in Race for First Bispecific ADC Approval: GlobalData

With 21 global approvals, ADCs generated USD 13.6 billion in 2024. BsADCs represent further opportunities in this field, by leveraging bi-specific antibodies that simultaneously bind two distinct targets.

Bristol Myers Squibb | 02/09/2025 | By Dineshwori

Biopharma Firms See 5.7 Percent Market Cap Drop in Q2 2025: Globaldata

Twenty biopharmaceutical companies have reported a 5.7 percent quarter-on-quarter (QoQ) downturn in their combined market capitalisation from USD 3.9 trillion on 31 March, 2025 to USD 3.7 trillion on 30 June, 2025.

Bristol Myers Squibb | 01/09/2025 | By Dineshwori

Scenic Biotech Partners with Alnylam to Advance RNAi Therapeutics Using Cell-Seq Platform

This collaboration represents Scenic Biotech’s third Cell-Seq collaboration with major US biotech and pharmaceutical companies, following ongoing multi-year agreements with Genentech and Bristol Myers Squibb. <br />

Bristol Myers Squibb | 26/08/2025 | By Dineshwori

Evotec Announces Progress in its Collaboration with Bristol Myers Squibb

Evotec and Bristol Myers Squibb entered their strategic neuroscience collaboration in December 2016 to identify disease-modifying treatments for a broad range of neurodegenerative diseases where there remains a significant unmet medical need for therapies that slow down or reverse disease progression.

Bristol Myers Squibb | 12/08/2024 | By Aishwarya |  324

Bristol Myers Squibb Gets US FDA Approval for Breyanzi

Bristol Myers Squibb has declared that US Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi.

Bristol Myers Squibb | 17/05/2024 | By Aishwarya |  535

Scenic Biotech Enters into Research Partnership with Bristol Myers Squibb

Scenic Biotech has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb’s drug targets by identifying target biology for indication selection and expansion.

Bristol Myers Squibb | 01/05/2024 | By Aishwarya |  298

Bristol Myers Squibb to invest Rs 800 Cr in setting up R&D facility in Telangana

The company intends to begin operations in Hyderabad later in 2023

Bristol Myers Squibb | 24/02/2023 | By Sudeep Soparkar |  715

Autoimmune drug by Bristol Myers shows potential in lupus

Deucravacitinib is one of nine new drugs that Bristol Myers executives believe will help offset revenue losses

Bristol Myers Squibb | 08/06/2022 | By Sudeep Soparkar |  708